Markets
markets
Luke Kawa

Why Nvidia and AMD’s unusual agreement with the Trump administration might survive any legal challenges

There is one glaring issue with the highly unusual arrangement that’s seen Nvidia and Advanced Micro Devices secure export licenses to China for chips that had previously faced restrictions in return for giving the US government 15% of the revenues generated by those sales:

Legal experts say it is of very dubious legality, to put it mildly.

“No matter the substantive merits of that pushback — this and other potential future deals like it are unlikely to be struck down by the courts (and sales and government revenue thereby interrupted) anytime soon,” George Pollack, a senior US policy analyst at Signum Global Research, wrote.

The first reason is the issue of standing, or rather, who can claim to have been hurt by this agreement.

Here are two people with law degrees discussing this very point, and one person who has watched “Law & Order” musing about the potential for this to end up in the courts.

(I would be very amused by Nvidia and/or AMD shareholders arguing that they’ve suffered from management agreeing to the 15% fee and not being able to benefit from what the full sales, not just 85% of them, would mean for those companies’ bottom lines and their potential returns.)

Pollack argues that Nvidia and AMD themselves would be unlikely to pursue a legal battle (given, you know, they agreed to this), and that Congress, trade associations, or the state of California would face difficulties getting a court to see things their way.

Secondly, the analyst flagged that there are two potential technical loopholes the Trump administration could turn to in order to avoid having this deal overturned by the courts:

  1. The chips themselves are physically not produced in the US, so “they do not technically qualify as ‘exports’ in the constitutional sense,” he wrote.

  2. “The 15% revenue share is entered into voluntarily by the companies, it is therefore not a mandated ‘fee’,” he noted.

More Markets

See all Markets
markets

Oscar Health jumps after Trump signals openness to extending ACA subsidies as part of deal to end government shutdown

Oscar Health jumped in after-hours trading after President Trump suggested he is open to extending Affordable Care Act subsidies as part of a funding bill to reopen the government.

The stock was recently up 9.1%.

ACA plans, which are a major source of revenue for some insurers, including Oscar, are at the center of budget negotiations as the government shutdown stretches on.

According to NBC News, when asked if he would be willing to make a deal on the subsidies, Trump told reporters: “If we made the right deal, I’d make a deal.” Senate Minority Leader Chuck Schumer denied that Trump was talking with Democrats about reaching an agreement but said, “We’ll be at the table,” The New York Times reported.

markets

Constellation Brands earnings report beats Wall Street estimates

Constellation Brands ticked up in after-hours trading Monday after it reported earnings results that beat Wall Street expectations.

Constellation, which owns a variety of booze brands including Modelo Especial in the US, reported quarterly adjusted earnings per share of $3.63, higher than the $3.38 analysts polled by FactSet were expecting.

It also reported $2.48 billion in revenue, slightly above the $2.45 billion the Street predicted.

The company slashed its full-year guidance last month, reducing its fiscal 2026 adjusted EPS outlook to $11.30 to $11.60, down from its previous range of $12.60 to $12.90. Analysts are penciling in $11.49 adjusted earnings per share for the fiscal year.

The company left that guidance unchanged.

Despite owning one of the US’s most sold beers, Constellation is facing various headwinds ranging from declining beer consumption and pressure on Hispanic consumers.

markets

AppLovin craters after Bloomberg report that the SEC is investigating its data collection practices

What AppLovin CEO Adam Foroughi said would be “a fun quarter” is turning unfun in a hurry.

Shares of the ad tech company tumbled after Bloomberg reported that its data collection practices are the subject of an SEC probe, in particular whether it violated service agreements in a bid to push higher volumes of targeted advertisements.

Citing people familiar with the matter, Bloomberg says the investigation is in response to a whistleblower complaint as well as reports from short sellers, some of which were published in February.

Confusion concept revenue sharing deals

It’s getting pretty tough keeping all these AI deals straight

Where is all this money supposed to come from? And who gets to keep it?

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.